Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,150 | 2 | 85.2% |
| Food and Beverage | $684.30 | 25 | 14.1% |
| Education | $34.79 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,229 | 6 | $0 (2020) |
| Puma Biotechnology, Inc. | $1,118 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $125.00 | 1 | $0 (2021) |
| Allergan Inc. | $99.36 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $48.63 | 3 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $39.07 | 3 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $33.65 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $27.00 | 2 | $0 (2018) |
| AUGMENIX, INC. | $21.18 | 1 | $0 (2017) |
| Boston Scientific Corporation | $18.77 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $18.77 | 1 | Boston Scientific Corporation ($18.77) |
| 2021 | $125.00 | 1 | Daiichi Sankyo Inc. ($125.00) |
| 2020 | $3,150 | 1 | AstraZeneca Pharmaceuticals LP ($3,150) |
| 2019 | $177.68 | 7 | Allergan Inc. ($99.36) |
| 2018 | $1,201 | 7 | Puma Biotechnology, Inc. ($1,118) |
| 2017 | $197.08 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($39.07) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/22/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/13/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: Oncology | ||||||
| 09/18/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $99.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/29/2019 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Oncology | ||||||
| 05/22/2019 | Array BioPharma Inc. | Braftovi (Drug), Mektovi | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Melanoma | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $12.51 | General |
| 03/13/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Oncology | ||||||
| 03/07/2019 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Oncology | ||||||
| 02/13/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 09/06/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: Oncology | ||||||
| 08/16/2018 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $22.28 | General |
| 07/24/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 05/30/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA, DARZALEX | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 01/24/2018 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Oncology | ||||||
| 01/24/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/29/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Oncology | ||||||
| 06/29/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Oncology | ||||||
| 06/27/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), YONDELIS, DARZALEX | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Oncology | ||||||
| 06/15/2017 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: UROLOGY | ||||||
| 05/19/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Oncology | ||||||
| 05/10/2017 | AUGMENIX, INC. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 04/07/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), KISQALI | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 541 | 1,241 | $653,353 | $84,744 |
| 2022 | 15 | 510 | 1,390 | $710,815 | $93,701 |
| 2021 | 17 | 488 | 1,248 | $597,726 | $79,690 |
| 2020 | 16 | 476 | 1,331 | $618,191 | $84,031 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 73 | 150 | $159,300 | $22,058 | 13.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 73 | 493 | $123,250 | $17,161 | 13.9% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 30 | 32 | $67,936 | $10,483 | 15.4% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 48 | 50 | $75,950 | $6,480 | 8.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 28 | 30 | $32,790 | $5,273 | 16.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 36 | 36 | $22,176 | $4,953 | 22.3% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 51 | 105 | $58,380 | $4,946 | 8.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 42 | 133 | $38,038 | $3,387 | 8.9% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 13 | 13 | $15,769 | $2,285 | 14.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 58 | 86 | $10,406 | $2,062 | 19.8% |
| 77470 | Special radiation treatment | Facility | 2023 | 19 | 19 | $10,070 | $1,580 | 15.7% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 22 | 24 | $19,536 | $1,541 | 7.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 13 | $6,370 | $1,315 | 20.6% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 22 | 23 | $9,982 | $677.35 | 6.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 14 | 34 | $3,400 | $541.96 | 15.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 72 | 178 | $189,036 | $26,173 | 13.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 76 | 599 | $149,750 | $20,972 | 14.0% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 33 | 35 | $74,305 | $11,476 | 15.4% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 33 | 37 | $40,441 | $6,519 | 16.1% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 43 | 47 | $71,393 | $5,990 | 8.4% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 47 | 96 | $53,376 | $4,539 | 8.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 46 | 173 | $49,478 | $4,416 | 8.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 25 | 25 | $15,400 | $3,513 | 22.8% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 13 | 13 | $15,769 | $2,297 | 14.6% |
| 77470 | Special radiation treatment | Facility | 2022 | 23 | 25 | $13,250 | $2,093 | 15.8% |
About Dr. Michael Christensen, M.D
Dr. Michael Christensen, M.D is a Radiation Oncology healthcare provider based in Franklin, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1497911275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Christensen, M.D has received a total of $4,869 in payments from pharmaceutical and medical device companies, with $18.77 received in 2022. These payments were reported across 29 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($4,150).
As a Medicare-enrolled provider, Christensen has provided services to 2,015 Medicare beneficiaries, totaling 5,210 services with total Medicare billing of $342,166. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Franklin, WI
- Active Since 07/31/2008
- Last Updated 10/29/2025
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1497911275
Products in Payments
- IMFINZI (Drug) $3,150
- Nerlynx (Drug) $1,118
- INJECTAFER (Drug) $125.00
- TEFLARO (Drug) $99.36
- PROVENGE (Drug) $33.65
- Erleada (Drug) $29.97
- AFINITOR (Drug) $27.00
- Xofigo (Drug) $25.57
- SpaceOAR (Device) $21.18
- SpaceOAR VUE System - 10mL (Device) $18.77
- ZYTIGA (Drug) $18.66
- CALQUENCE (Drug) $17.61
- Braftovi (Drug) $15.68
- FASLODEX (Drug) $15.44
- Xtandi (Drug) $14.85
- VPRIV (Biological) $14.41
- FIRMAGON (Drug) $14.40
- VYXEOS (Drug) $13.60
- Stivarga (Drug) $13.50
- SYNDROS (Drug) $12.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.